XNCR.NASDAQXencor INC

Form 4: Xencor Insider Acquires Shares, Granted Stock Options

Sentiment:

Insider Transaction Report


Raymond Joseph Deshaies of Xencor Inc. acquired 10,302 shares of common stock and was granted options for 20,604 shares, with vesting schedules detailed.

Summary

  • Raymond Joseph Deshaies, a reporting person associated with Xencor Inc., acquired 10,302 shares of common stock on June 16, 2026, at no cost.
  • Additionally, Deshaies was granted stock options (right to buy) for 20,604 shares of common stock on June 16, 2026.
  • The acquired shares are directly beneficially owned.
  • The stock options have an exercise price of $12.20 and will vest in equal monthly installments over one year, starting one month after June 16, 2026, fully vesting by June 16, 2027.
  • The underlying securities for the options are 20,604 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider equity grants and acquisitions rather than significant strategic shifts or financial performance indicators.

Positives

  • Acquisition of 10,302 shares of common stock by a reporting person.
  • Grant of stock options for 20,604 shares, indicating potential future equity ownership and alignment with company performance.
  • Clear vesting schedule for stock options, providing a defined path to ownership.

Negatives

  • The filing does not contain information that can be construed as negative.

Risks

  • The value of the stock options is subject to market fluctuations and the company's future performance.
  • Vesting of options is contingent on continued employment or service with the company.

Future Outlook

The filing details the vesting schedule for stock options, indicating a future potential increase in beneficial ownership for Raymond Joseph Deshaies upon vesting.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, reflecting typical compensation and equity incentive practices within the biotechnology and pharmaceutical sectors, where Xencor operates.

Stakeholder Impact

  • Shareholders: The transaction reflects standard executive compensation practices and does not immediately alter the company's outstanding share count or financial position.

Next Steps

  • Vesting of stock options over the next year.
  • Potential exercise of vested stock options by Raymond Joseph Deshaies.

Key Dates

DateDescription
06/16/2026Earliest transaction date, date of common stock acquisition, and date of stock option grant.
06/15/2036Expiration date of stock options.
06/16/2027Date by which all granted stock options will be fully vested.
07/08/2026Date of signature for the filing.

Keywords

Xencor Inc, XNCR, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Securities Exchange Act, Raymond Joseph Deshaies

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.